Use of tlr7/8 agonists for the treatment ofinfections in cirrhotic patients

The present invention relates to methods and pharmaceutical compositions for the treatment of bacterial infections in patients suffering from cirrhosis. In particular, the present invention relates to a method of treating bacterial infection in a patient suffering from cirrhosis comprising administering to the patient a therapeutically effective amount of a TLR7 and/or TLR8 agonist.

Keywords: cirrhosis, TLR7 and TLR8 agonist, Infectious diseases, bacterial peritonitis, small molecule, CL097
Patent Application number: EP15306912.5
Inventors:
Axel PERIANINLoïc ROLAS

Reference:

BIO15052-T1

To learn more, please contact us:

Inserm Transfert
Business Developer
Patent filling date: 2015-12-02
Second indication: Yes

You might also be interested in

Contact

Inserm Transfert

Research tool licensing team

researchtools@inserm-transfert.fr